Furthermore, Zhang et al. successfully established and characterized patient-derived esophageal squamous cell carcinoma xenograft (PDECX) mouse models, and found that PDECX models with PIK3CA mutation had no significant response to cytotoxic agents. The gene discussed is PIK3CA; the disease is esophageal squamous cell carcinoma.